In a new study published in Lupus Science & Medicine, researchers assessed clinical trial perceptions among a predominantly Black cohort of participants with systemic lupus erythematosus (SLE).
The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene ...
Serving north, central and west Texas, including Dallas/Fort Worth, San Antonio, Austin, El Paso, Lubbock, and surrounding areas Join us for the 2025 Portland Lupus & You Empowerment Conference! Lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback